AI Benefits PBMs, Health Plans and Formulary Decision Making | AMCP Nexus 2024
Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making processes, according to Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy.
Douglas S. Burgoyne, Pharm.D., MBA, FAMCP, adjunct associate professor at the University of Utah College of Pharmacy, said that while it has some complexities, AI is largely beneficial.
“In terms of data aggregation and summarization for trending and reporting, it's tremendously valuable for us,” Burgoyne. “It takes less time for our analysts to do their job, which makes the clinical pharmacy team better able to respond quickly and hopefully to make even better decisions in terms of formulary.”
Burgoyne attended AMCP Nexus 2024 last week, held at the MGM Grand in Las Vegas. He spoke at two sessions. The first was ‘AI in Healthcare: From Cutting Edge Innovations to Practical Applications in Formulary Decision Making.’ The second was called, ‘Executive to Executive: Leading Managed Care Organizations Today.’
“In terms of data aggregation and summarization for trending and reporting, it's tremendously valuable for us,” Burgoyne. “It takes less time for our analysts to do their job, which makes the clinical pharmacy team better able to respond quickly and hopefully to make even better decisions in terms of formulary.”
Burgoyne attended AMCP Nexus 2024 last week, held at the MGM Grand in Las Vegas. He spoke at two sessions. The first was ‘AI in Healthcare: From Cutting Edge Innovations to Practical Applications in Formulary Decision Making.’ The second was called, ‘Executive to Executive: Leading Managed Care Organizations Today.’
Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research.
Read More
How Technology Benefits Specialty Pharmacy | AMCP 2024
October 18th 2024Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and Research, explains how technology identifies at-risk patients, coordinates medication refills and more.
Read More
Cancer’s Reign Over the Drug Development Pipeline Continues| AMCP Nexus 2024
October 18th 2024The FDA has already made more than a dozen cancer drug approval decisions this year and more expected in the next several months and in early 2025, according to Kaelyn Boss, who gave an oncology drug pipeline talk at the 2024 AMCP Nexus meeting this week.
Read More
